As of April 18, 2025, TME Pharma NV (ALTME.PA) has a market cap of $7.272 million USD. According to our data, TME Pharma NV is ranked No.8903 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $7.27 M |
-9.60%
|
Dec 31, 2024 | $8.04 M |
-67.39%
|
Dec 29, 2023 | $24.67 M |
1,986.97%
|
Dec 30, 2022 | $1.18 M |
-94.80%
|
Dec 31, 2021 | $22.75 M |
-58.36%
|
Dec 31, 2020 | $54.64 M |
-3.44%
|
Dec 31, 2019 | $56.59 M |
-42.94%
|
Dec 31, 2018 | $99.17 M |
-83.94%
|
Dec 29, 2017 | $0.62 B |
-71.12%
|
Dec 30, 2016 | $2.14 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sea (Garena)
SE
|
$69.48 B |
5.508 B
|
![]() Singapore
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() Curevac
CVAC
|
$0.70 B |
0.000 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
Market Cap | = | ALTME.PA Stock Price | * | ALTME.PA Shares Outstanding |
= | $0.07 | * | 94.12 M | |
= | $7.27 M |